MDA-MB-231 breast cancer cells were silenced with doxycycline (Dox)-inducible short hairpin RNAs (shRNAs) targeting DAP5 (MB-231-shDAP5) or a non-silencing control (MB-231-shNSi). This evidence concerns the gene EIF4G2 and breast carcinoma.